Gross Profit for Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's current gross profit (TTM) is $6.91B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$6.91B
YoY change
-6.1%
5Y CAGR
-9.9%
Peak year (2019)
$12.42B
Cumulative gross profit
$152.39B
Gross Profit history chart for Biogen (BIIB) from 1985 to 2025
Gross Profit history table for Biogen (BIIB) from 1985 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $6.91B | -6.1% | ||
| 2024 | $7.37B | +0.9% | ||
| 2023 | $7.30B | -7.5% | ||
| 2022 | $7.90B | -11.0% | ||
| 2021 | $8.87B | -23.8% | ||
| 2020 | $11.64B | -6.3% | ||
| 2019 | $12.42B | +6.8% | ||
| 2018 | $11.64B | +9.3% | ||
| 2017 | $10.64B | +6.3% | ||
| 2016 | $10.02B | +5.2% | ||
| 2015 | $9.52B | +11.6% | ||
| 2014 | $8.53B | +40.5% | ||
| 2013 | $6.07B | +22.2% | ||
| 2012 | $4.97B | +8.5% | ||
| 2011 | $4.58B | +6.2% | ||
| 2010 | $4.32B | +8.0% | ||
| 2009 | $4.00B | +8.1% | ||
| 2008 | $3.70B | +30.3% | ||
| 2007 | $2.84B | +17.8% | ||
| 2006 | $2.41B | +79.8% | ||
| 2005 | $1.34B | +28.7% | ||
| 2004 | $1.04B | -1156.2% | ||
| 2003 | -$98.61M | -124.5% | ||
| 2002 | $402.76M | -55.5% | ||
| 2001 | $905.80M | +13.2% | ||
| 2000 | $800.47M | +17.1% | ||
| 1999 | $683.43M | +41.5% | ||
| 1998 | $483.08M | +25.8% | ||
| 1997 | $383.86M | +54.4% | ||
| 1996 | $248.56M | +76.1% | ||
| 1995 | $141.19M | -3.6% | ||
| 1994 | $146.40M | +11.8% | ||
| 1993 | $130.90M | +7.7% | ||
| 1992 | $121.50M | +571.3% | ||
| 1991 | $18.10M | +23.1% | ||
| 1990 | $14.70M | +345.5% | ||
| 1989 | $3.30M | -760.0% | ||
| 1988 | -$500,000 | -96.0% | ||
| 1987 | -$12.40M | -26.6% | ||
| 1986 | -$16.90M | -259.4% | ||
| 1985 | $10.60M | — |
Gross Profit values are taken from Biogen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Biogen (BIIB) gross profit is $6.91B – declined 6.1% year-over-year.
Biogen gross profit has contracted on net over the period, with a -9.9% compound annual growth rate over 2020–2025 (5 years).
Biogen gross profit plunged from $12.42B in 2019 to $6.91B in 2025, a 44.3% drawdown.
The highest annual gross profit of $12.42B was reported in 2019. The lowest in the available history was -$98.61M in 2003.
Within Healthcare, Biogen (BIIB) ranks 9th among 8 peers we track. The peer median for gross profit is $53.80B.
Biogen Gross Profit by Year
Biogen Gross Profit 2025: $6.91B
Biogen gross profit in 2025 was $6.91B, declined 6.1% below 2024.
Biogen Gross Profit 2024: $7.37B
Biogen gross profit in 2024 was $7.37B, edged up 0.9% from 2023.
Biogen Gross Profit 2023: $7.30B
Biogen gross profit in 2023 was $7.30B, declined 7.5% below 2022.
Biogen Gross Profit 2022: $7.90B
Biogen gross profit in 2022 was $7.90B, declined 11.0% below 2021.
Biogen Gross Profit 2021: $8.87B
Biogen gross profit in 2021 was $8.87B.
See more financial history for Biogen (BIIB).
Sector peers — Gross Profit
Companies in the same sector as Biogen, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Biogen's gross profit?
- Latest reported gross profit for Biogen (BIIB) is $6.91B (period ending December 31, 2025).
How has Biogen gross profit changed year-over-year?
- Biogen (BIIB) gross profit changed -6.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Biogen gross profit?
- Biogen (BIIB) gross profit compound annual growth rate is -9.9% over the most recent 5 years available.
When did Biogen gross profit hit its highest annual value?
- Biogen gross profit reached its highest annual value of $12.42B in 2019.
What was Biogen gross profit in 2024?
- Biogen (BIIB) gross profit in 2024 was $7.37B.
What was Biogen gross profit in 2025?
- Biogen (BIIB) gross profit in 2025 was $6.91B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.